Specific hypertension smartphone app to improve medication adherence in hypertension: a cluster-randomized trial.
Digital interventions, such as smartphone applications (APP), are becoming an increasingly common way to support medication adherence and self-management in chronic illness. To evaluate the effectiveness of the intervention in pharmacological therapeutic adherence of the mild-moderate arterial hypertension (AHT), through an APP installed in the mobile phone, as well as the degree of control reached by the patient with this tool. Prospective, randomized controlled trial, full-study and multicenter study. Four primary care centers participated. One hundred and fifty-four hypertensive patients under antihypertensive treatment were included. Two groups were established: a control group (CG) with usual intervention (n = 77) and an intervention group (n = 77) (IG), targeting hypertensive people who owned and regularly used a mobile smartphone, specifically using the APP called ALERHTA to promote health education and reminder of appointments. There were 3 visits: initial, 6 and 12 months. Drugs adherence was measured by electronic monitors (MEMS). Primary outcome was average adherence percentage daily between 80 and 100% %, and the AHT control. 148 patients finished the study. Mean age 57.5 ± 9.9. Were considered adherents of the global sample 77.02% (CI =70.25-83.79) and 74.32% (CI =67.29-81.35%) adherents with the daily dose intake. Adherents once daily were 93.15% and 86.3% in IG and 70.66% and 62.66% in CG after 6 and 12 months respectively (p <0.05). The percentage of uncontrolled patients was 28.3% (CI =21.05-35.55%). The control of high blood pressure at 12 months was 17.8% and 38.6% for IG and CG respectively (p <0.05). The NNT was 4.23 patients. The intervention with an APP installed in the mobile phone of hypertensive patients favors the pharmacological therapeutic adherence and improves the percentage of hypertensive patient control. Spanish Agency of Medicine: EPA-SP UN-HTA-2015-01.